Burden and trends of endoscopically unresectable polyps requiring surgical intervention: A systematic review and meta-analysis
This systematic review and meta-analysis concludes that the burden of surgery for endoscopically unresectable colorectal polyps cannot be expressed as a single figure due to significant definitional inconsistencies across studies, though estimates converge when denominators match and surgical volumes appear to have peaked around 2012–2014 before declining.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
Inside the human colon, small growths called polyps are common, appearing in a significant portion of the adult population. Most of these growths are harmless and can be removed safely during a routine camera exam of the bowel, a procedure known as a colonoscopy. However, some polyps are too large, too flat, or located in difficult spots to be removed with standard tools. When doctors judge a polyp to be impossible to remove with a scope, they traditionally refer the patient for surgery to cut out a section of the colon. This operation is a major procedure with real risks and a long recovery, yet the polyp itself is often not cancer. As advanced techniques have improved, allowing doctors to remove more difficult growths without cutting, the question has arisen: how many people are still undergoing major surgery for these benign growths, and is that number going up or down?
A team of researchers set out to answer this by gathering every available study that tracked how often surgery was performed for these specific, hard-to-reach polyps. They did not just look for numbers; they looked at how those numbers were calculated. The researchers found that the medical literature was filled with estimates that seemed to contradict one another. Some studies suggested that surgery for these polyps was rare, affecting less than one percent of cases, while others suggested it was very common, affecting nearly forty percent of certain groups. The team realized that these wildly different numbers were not necessarily because patients in different countries had different diseases, but because the studies were measuring different things. One study might count the surgery rate against the total number of colonoscopies performed, while another counted it against the total number of colon surgeries done for any reason, and a third counted it against the total number of polyps found. Because the "total" being measured changed from study to study, the resulting percentages could not be compared directly.
To make sense of this, the researchers organized the data into four distinct categories based on what was being counted in the denominator, or the total group being measured. They looked at rates per population, rates per all colon surgeries, rates per all polyps found, and rates per all colonoscopies. When they grouped the studies by these specific definitions, the confusion began to clear. They found that when the definition of the total group was the same, the estimates from different studies actually agreed closely. For example, when looking at the proportion of all colonoscopies that resulted in surgery for these polyps, studies from different continents produced nearly identical results, hovering around a quarter of one percent. This revealed that the disagreement in the field was not about the actual number of surgeries, but about how the data was presented.
The researchers also examined the criteria doctors used to decide a polyp was "unresectable," or impossible to remove with a scope. They found that in the vast majority of studies, these criteria were either missing entirely or described so vaguely that another doctor could not repeat the decision. Only one study out of seventeen clearly stated the rules used to label a polyp as unresectable. This lack of clear definition meant that one study might be counting only the most difficult cases, while another included any polyp that required a surgeon, leading to vastly different numbers even when looking at the same type of patient.
Looking at the timeline of the data, the researchers identified a clear shift in practice over time. Studies covering the period before 2014 generally showed an increase in the number of surgeries for these polyps. However, studies covering the years from 2012 through 2024 showed a consistent decline across all categories. This suggests that as advanced endoscopic techniques became more widespread and refined, fewer patients were being sent to the operating room for growths that could now be managed without cutting. The peak of surgical intervention appears to have occurred around 2012 to 2014, after which the numbers began to fall.
Despite these insights, the researchers concluded that it is currently impossible to give a single, definitive number for how many people undergo surgery for these polyps. The variation in how studies define their totals and how they identify the polyps makes a single summary figure misleading. The evidence suggests that the burden of surgery is real but is being measured in many different ways that do not align. To move forward, the medical community needs a standard way to report these numbers, ensuring that when a study says a certain percentage of patients had surgery, everyone understands exactly what group that percentage represents. Until then, the true scale of the problem remains hidden behind a wall of inconsistent definitions, even as the trend clearly points toward fewer operations being performed.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.